{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T16:02:42Z","timestamp":1785340962697,"version":"3.55.0"},"reference-count":97,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Clinical Electrophysiology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jacep.2026.05.002","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T20:52:20Z","timestamp":1781815940000},"page":"1745-1759","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Selective Use of Nonselective Beta-Blockers"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8814-0969","authenticated-orcid":false,"given":"Davide","family":"Genovese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Sgarito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donatella","family":"Ruggiero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4322-1183","authenticated-orcid":false,"given":"Laura","family":"Perrotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Francia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9909-6513","authenticated-orcid":false,"given":"Francesco","family":"Santoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4733-9418","authenticated-orcid":false,"given":"Giacomo","family":"Mugnai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacep.2026.05.002_bib1","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1161\/CIR.0000000000000659","article-title":"Heart Disease and Stroke Statistics\u20142019 update: a report from the American Heart Association","volume":"139","author":"Benjamin","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2026.05.002_bib2","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacep.2026.05.002_bib3","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacep.2026.05.002_bib4","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","article-title":"2022 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"43","author":"Zeppenfeld","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacep.2026.05.002_bib5","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1136\/heartjnl-2020-318881","article-title":"Temporal trends and sex differences in sudden cardiac death in the Copenhagen City Heart Study","volume":"107","author":"\u00c5gesen","year":"2021","journal-title":"Heart"},{"key":"10.1016\/j.jacep.2026.05.002_bib6","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1161\/CIRCEP.113.001034","article-title":"Public health burden of sudden cardiac death in the United States","volume":"7","author":"Stecker","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacep.2026.05.002_bib7","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.pcad.2008.01.003","article-title":"The role of the autonomic nervous system in sudden cardiac death","volume":"50","author":"Vaseghi","year":"2008","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.jacep.2026.05.002_bib8","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1161\/CIRCRESAHA.113.302549","article-title":"Role of the autonomic nervous system in modulating cardiac arrhythmias","volume":"114","author":"Shen","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.jacep.2026.05.002_bib9","article-title":"Beta-blockers in cardiac arrhythmias\u2014clinical pharmacologist's point of view","volume":"13","author":"Wo\u0142owiec","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jacep.2026.05.002_bib10","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/j.jacc.2009.05.015","article-title":"The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications","volume":"54","author":"Triposkiadis","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2026.05.002_bib11","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.ehj.2004.06.002","article-title":"Expert consensus document on beta-adrenergic receptor blockers","volume":"25","author":"L\u00f3pez-Send\u00f3n","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacep.2026.05.002_bib12","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/sj.bjp.0706048","article-title":"The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors","volume":"144","author":"Baker","year":"2005","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jacep.2026.05.002_bib13","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1472-8206.1991.tb00698.x","article-title":"Studies on the mechanism of arterial vasodilation produced by the novel antihypertensive agent, carvedilol","volume":"5","author":"Nichols","year":"1991","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.jacep.2026.05.002_bib14","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1161\/CIRCULATIONAHA.104.532960","article-title":"Endothelial \u03b23-adrenoreceptors mediate nitric oxide\u2013dependent vasorelaxation of coronary microvessels in response to the third-generation \u03b2-blocker nebivolol","volume":"112","author":"Dessy","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2026.05.002_bib15","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0022-3565(25)20919-3","article-title":"Electrophysiologic and voltage clamp analysis of the effects of sotalol on isolated cardiac muscle and Purkinje fibers","volume":"232","author":"Carmeliet","year":"1985","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jacep.2026.05.002_bib16","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1056\/NEJM199407073310108","article-title":"Sotalol","volume":"331","author":"Hohnloser","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacep.2026.05.002_bib17","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3389\/fphar.2010.00144","article-title":"Propranolol blocks cardiac and neuronal voltage-gated sodium channels","volume":"1","author":"Wang","year":"2010","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jacep.2026.05.002_bib18","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0014-2999(99)00368-4","article-title":"Carvedilol blocks the repolarizing K+ currents and the L-type Ca2+ current in rabbit ventricular myocytes","volume":"376","author":"Cheng","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jacep.2026.05.002_bib19","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0008-6363(00)00265-0","article-title":"Antiarrhythmic drug carvedilol inhibits HERG potassium channels","volume":"49","author":"Karle","year":"2001","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacep.2026.05.002_bib20","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1365-2125.1981.tb01169.x","article-title":"Beta-adrenoceptor blockers and the blood-brian barrier","volume":"11","author":"Neil-Dwyer","year":"1981","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jacep.2026.05.002_bib21","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1161\/01.CIR.75.1.204","article-title":"Central nervous system effects of beta-adrenergic-blocking drugs: the role of ancillary properties","volume":"75","author":"Kostis","year":"1987","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2026.05.002_bib22","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0002-9149(87)90804-6","article-title":"Electrophysiologic effects, clinical efficacy and safety of intravenous and oral nadolol in refractory supraventricular tachyarrhythmias","volume":"59","author":"Saksena","year":"1987","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacep.2026.05.002_bib23","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/clpt.1983.193","article-title":"Kinetics of esmolol, an ultra-short-acting beta blocker, and of its major metabolite","volume":"34","author":"Sum","year":"1983","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jacep.2026.05.002_bib24","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2133\/dmpk.20.337","article-title":"Pharmacokinetics and pharmacodynamics of landiolol hydrochloride, an ultra short-acting beta1-selective blocker, in a dose escalation regimen in healthy male volunteers","volume":"20","author":"Murakami","year":"2005","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.jacep.2026.05.002_bib25","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s00392-023-02295-0","article-title":"Efficacy and safety of intravenous beta-blockers in acute atrial fibrillation and flutter is dependent on beta-1 selectivity: a systematic review and meta-analysis of randomised trials","volume":"113","author":"Perrett","year":"2024","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.jacep.2026.05.002_bib26","article-title":"Carvedilol for prevention of atrial fibrillation after cardiac surgery: a meta-analysis","volume":"9","author":"Wang","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.jacep.2026.05.002_bib27","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-038364","article-title":"Metoprolol for prophylaxis of postoperative atrial fibrillation in cardiac surgery patients: systematic review and meta-analysis","volume":"10","author":"Norhayati","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.jacep.2026.05.002_bib28","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1093\/eurheartj\/ehl272","article-title":"Interventions for prevention of post-operative atrial fibrillation and its complications after cardiac surgery: a meta-analysis","volume":"27","author":"Burgess","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacep.2026.05.002_bib29","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0022-3565(25)10363-7","article-title":"Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger","volume":"263","author":"Yue","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jacep.2026.05.002_bib30","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/eurheartj\/ehs423","article-title":"Metoprolol vs. carvedilol or carvedilol plus N-acetyl cysteine on post-operative atrial fibrillation: a randomized, double-blind, placebo-controlled study","volume":"34","author":"Ozaydin","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacep.2026.05.002_bib31","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.jtcvs.2012.06.042","article-title":"Feasibility of landiolol and bisoprolol for prevention of atrial fibrillation after coronary artery bypass grafting: a pilot study","volume":"144","author":"Sezai","year":"2012","journal-title":"J Thoracic Cardiovasc Surg"},{"key":"10.1016\/j.jacep.2026.05.002_bib32","first-page":"581","article-title":"Nebivolol in preventing atrial fibrillation following coronary surgery in patients over 60 years of age","volume":"29","author":"Erdil","year":"2014","journal-title":"Rev Bras Cir Cardiovasc"},{"key":"10.1016\/j.jacep.2026.05.002_bib33","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/j.jacep.2023.06.009","article-title":"Effect of carvedilol vs metoprolol on atrial and ventricular arrhythmias among implantable cardioverter-defibrillator recipients","volume":"9","author":"Diamond","year":"2023","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.jacep.2026.05.002_bib34","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.amjcard.2010.08.062","article-title":"Comparison of effectiveness of carvedilol versus bisoprolol for prevention of postdischarge atrial fibrillation after coronary artery bypass grafting in patients with heart failure","volume":"107","author":"Marazzi","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacep.2026.05.002_bib35","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1253\/circj.CJ-09-0989","article-title":"Comparative effects of carvedilol vs bisoprolol for severe congestive heart failure","volume":"74","author":"Konishi","year":"2010","journal-title":"Circ J"},{"key":"10.1016\/j.jacep.2026.05.002_bib36","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1016\/S0140-6736(14)61373-8","article-title":"Efficacy of \u03b2 blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis","volume":"384","author":"Kotecha","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jacep.2026.05.002_bib37","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1053\/euhj.2000.2546","article-title":"Maintenance of sinus rhythm after electrical cardioversion of persistent atrial fibrillation; sotalol vs bisoprolol","volume":"22","author":"Plewan","year":"2001","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacep.2026.05.002_bib38","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.amjcard.2003.07.009","article-title":"Comparison of effectiveness of carvedilol versus bisoprolol for maintenance of sinus rhythm after cardioversion of persistent atrial fibrillation","volume":"92","author":"Katritsis","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacep.2026.05.002_bib39","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jacc.2004.10.068","article-title":"Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study","volume":"45","author":"Wachtell","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2026.05.002_bib40","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/eurheartj\/ehz467","article-title":"2019 ESC Guidelines for the management of patients with supraventricular tachycardia. The Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC)","volume":"41","author":"Brugada","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacep.2026.05.002_bib41","doi-asserted-by":"crossref","first-page":"33f","DOI":"10.1016\/0002-9149(85)90914-2","article-title":"Comparative efficacy and tolerance of esmolol to propranolol for control of supraventricular tachyarrhythmia","volume":"56","author":"Morganroth","year":"1985","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacep.2026.05.002_bib42","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13613-024-01418-8","article-title":"Comparison of the efficacy and safety of landiolol and esmolol in critically ill patients: a propensity score-matched study","volume":"15","author":"Si","year":"2025","journal-title":"Ann Intensive Care"},{"issue":"13","key":"10.1016\/j.jacep.2026.05.002_bib43","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/j.jacc.2015.09.019","article-title":"2015 ACC\/AHA\/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society","volume":"67","author":"Page","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2026.05.002_bib44","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00246-016-1544-y","article-title":"Nadolol for treatment of supraventricular tachycardia in infants and young children","volume":"38","author":"von Alvensleben","year":"2017","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.jacep.2026.05.002_bib45","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1016\/j.jacc.2018.02.056","article-title":"Propranolol versus metoprolol for treatment of electrical storm in patients with implantable cardioverter-defibrillator","volume":"71","author":"Chatzidou","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2026.05.002_bib46","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/j.jacc.2018.02.058","article-title":"Why is propranolol better than metoprolol in acute treatment of electrical storm?","volume":"71","author":"Chen","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2026.05.002_bib47","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3325\/cmj.2014.55.75","article-title":"Propranolol efficiency in prevention of sustained ventricular tachycardia in patients with implanted cardioverter-defibrillator: a case series","volume":"55","author":"Puljevi\u0107","year":"2014","journal-title":"Croat Med J"},{"key":"10.1016\/j.jacep.2026.05.002_bib48","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1161\/01.CIR.0000035653.72855.BF","article-title":"Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study","volume":"106","author":"Packer","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2026.05.002_bib49","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","article-title":"Effect of metoprolol CR\/XL in chronic heart failure: Metoprolol CR\/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jacep.2026.05.002_bib50","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(98)11181-9","article-title":"The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jacep.2026.05.002_bib51","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.f55","article-title":"Benefits of \u03b2 blockers in patients with heart failure and reduced ejection fraction: network meta-analysis","volume":"346","author":"Chatterjee","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.jacep.2026.05.002_bib52","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1056\/NEJM199906173402402","article-title":"Prevention of implantable-defibrillator shocks by treatment with sotalol. d,l-Sotalol Implantable Cardioverter-Defibrillator Study Group","volume":"340","author":"Pacifico","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacep.2026.05.002_bib53","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0002-9149(98)00478-0","article-title":"Comparison of metoprolol and sotalol in preventing ventricular tachyarrhythmias after the implantation of a cardioverter\/defibrillator","volume":"82","author":"Seidl","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacep.2026.05.002_bib54","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1046\/j.1460-9592.2002.01571.x","article-title":"Efficacy of metoprolol and sotalol in the prevention of recurrences of sustained ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillator","volume":"25","author":"Kettering","year":"2002","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.jacep.2026.05.002_bib55","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(03)13800-7","article-title":"Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial","volume":"362","author":"Poole-Wilson","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jacep.2026.05.002_bib56","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ahj.2004.10.002","article-title":"Effects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure\u2014COMET","volume":"149","author":"Torp-Pedersen","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacep.2026.05.002_bib57","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/clc.23144","article-title":"A comparison of anti-arrhythmic efficacy of carvedilol vs metoprolol succinate in patients with implantable cardioverter-defibrillators","volume":"42","author":"Ayan","year":"2019","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jacep.2026.05.002_bib58","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1016\/S0735-1097(99)00134-5","article-title":"Long-term effects of carvedilol in idiopathic dilated cardiomyopathy with persistent left ventricular dysfunction despite chronic metoprolol. The Heart-Muscle Disease Study Group","volume":"33","author":"Di Lenarda","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2026.05.002_bib59","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.amjcard.2012.11.031","article-title":"Meta-analysis of carvedilol versus beta 1 selective beta-blockers (atenolol, bisoprolol, metoprolol, and nebivolol)","volume":"111","author":"DiNicolantonio","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacep.2026.05.002_bib60","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/europace\/euq164","article-title":"Influence of beta-blocker therapy on antitachycardia pacing effectiveness for monomorphic ventricular tachycardias occurring in implantable cardioverter-defibrillator patients: a dose-dependent effect","volume":"12","author":"Jim\u00e9nez-Candil","year":"2010","journal-title":"Europace"},{"key":"10.1016\/j.jacep.2026.05.002_bib61","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1093\/eurheartj\/ehy811","article-title":"\u03b2-blockers, calcium antagonists, and mortality in stable coronary artery disease: an international cohort study","volume":"40","author":"Sorbets","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacep.2026.05.002_bib62","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1001\/jama.2012.12559","article-title":"\u03b2-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease","volume":"308","author":"Bangalore","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.jacep.2026.05.002_bib63","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1093\/eurheartj\/ehy077","article-title":"International Expert Consensus Document on Takotsubo Syndrome (Part II): diagnostic workup, outcome, and management","volume":"39","author":"Ghadri","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacep.2026.05.002_bib64","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/1755-5922.12182","article-title":"Hemodynamic effects, safety, and feasibility of intravenous esmolol infusion during Takotsubo cardiomyopathy with left ventricular outflow tract obstruction: results from a multicenter registry","volume":"34","author":"Santoro","year":"2016","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/j.jacep.2026.05.002_bib65","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/heartjnl-2023-322980","article-title":"Beta-blockers and renin-angiotensin system inhibitors for Takotsubo syndrome recurrence: a network meta-analysis","volume":"110","author":"Santoro","year":"2024","journal-title":"Heart"},{"key":"10.1016\/j.jacep.2026.05.002_bib66","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.jchf.2024.11.015","article-title":"Beta-blockers and long-term mortality in Takotsubo syndrome","volume":"13","author":"Raposeiras-Roubin","year":"2025","journal-title":"JACC Heart Failure"},{"key":"10.1016\/j.jacep.2026.05.002_bib67","first-page":"e558","article-title":"2020 AHA\/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"142","author":"Ommen","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2026.05.002_bib68","doi-asserted-by":"crossref","first-page":"e578","DOI":"10.1161\/CIR.0000000000000560","article-title":"Evaluation and management of right-sided heart failure: a scientific statement from the American Heart Association","volume":"137","author":"Konstam","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2026.05.002_bib69","doi-asserted-by":"crossref","first-page":"e301","DOI":"10.1016\/j.hrthm.2019.05.007","article-title":"2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy","volume":"16","author":"Towbin","year":"2019","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2026.05.002_bib70","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/eurheartj\/ehx596","article-title":"Lamin A\/C cardiomyopathy: young onset, high penetrance, and frequent need for heart transplantation","volume":"39","author":"Hasselberg","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacep.2026.05.002_bib71","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1161\/CIRCULATIONAHA.121.056018","article-title":"An international multicenter cohort study on \u03b2-blockers for the treatment of symptomatic children with catecholaminergic polymorphic ventricular tachycardia","volume":"145","author":"Peltenburg","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2026.05.002_bib72","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.hrthm.2015.09.029","article-title":"Nadolol decreases the incidence and severity of ventricular arrhythmias during exercise stress testing compared with \u03b21-selective \u03b2-blockers in patients with catecholaminergic polymorphic ventricular tachycardia","volume":"13","author":"Leren","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2026.05.002_bib73","doi-asserted-by":"crossref","first-page":"e921","DOI":"10.1016\/j.hrthm.2025.05.053","article-title":"The clinical and electrocardiographic phenotype of patients with genotype-negative long QT syndrome","volume":"22","author":"Karlinski Vizentin","year":"2025","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2026.05.002_bib74","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0185680","article-title":"Effectiveness of beta-blockers depending on the genotype of congenital long-QT syndrome: a meta-analysis","volume":"12","author":"Ahn","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.jacep.2026.05.002_bib75","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.579525","article-title":"The efficacy of beta-blockers in patients with long QT syndrome 1-3 according to individuals\u2019 gender, age, and QTc intervals: a network meta-analysis","volume":"11","author":"Han","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jacep.2026.05.002_bib76","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00246-003-0567-3","article-title":"Beta-blocker therapy failures in symptomatic probands with genotyped long-QT syndrome","volume":"25","author":"Chatrath","year":"2004","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.jacep.2026.05.002_bib77","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1161\/CIRCULATIONAHA.116.021823","article-title":"Clinical aspects of type 3 long-QT syndrome: an international multicenter study","volume":"134","author":"Wilde","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2026.05.002_bib78","article-title":"A systematic review on the role of beta-blockers in reducing cardiac arrhythmias in Long QT syndrome subtypes 1-3","volume":"13","author":"Went","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.jacep.2026.05.002_bib79","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1046\/j.1540-8167.2005.40564.x","article-title":"Propranolol intoxication revealing a Brugada syndrome","volume":"16","author":"Aouate","year":"2005","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacep.2026.05.002_bib80","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/0735-1097(95)00613-3","article-title":"Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome","volume":"27","author":"Miyazaki","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2026.05.002_bib81","article-title":"Beta-blockers and their current role in maternal and neonatal health: a narrative review of the literature","volume":"15","author":"Martinez","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.jacep.2026.05.002_bib82","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.jacc.2006.09.054","article-title":"Long QT syndrome and pregnancy","volume":"49","author":"Seth","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2026.05.002_bib83","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-0731","article-title":"Late pregnancy \u03b2 blocker exposure and risks of neonatal hypoglycemia and bradycardia","volume":"138","author":"Bateman","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.jacep.2026.05.002_bib84","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/1471-0528.12522","article-title":"Treatment with oral beta-blockers during pregnancy complicated by maternal heart disease increases the risk of fetal growth restriction","volume":"121","author":"Ersb\u00f8ll","year":"2014","journal-title":"BJOG"},{"key":"10.1016\/j.jacep.2026.05.002_bib85","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/j.hrthm.2022.05.001","article-title":"Contemporary maternal and fetal outcomes in the treatment of LQTS during pregnancy: is nadolol bad for the fetus?","volume":"19","author":"Hammond","year":"2022","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2026.05.002_bib86","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/j.hrthm.2022.06.009","article-title":"Long QT syndrome, pregnancy, and nonselective \u03b2-blockers: efficacious for mom and safe for baby?","volume":"19","author":"Giudicessi","year":"2022","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2026.05.002_bib87","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1017\/S104795112511010X","article-title":"Beta-blocker prescription adherence of children and young people with long QT syndrome: a retrospective cohort study","volume":"35","author":"Kendall","year":"2025","journal-title":"Cardiol Young"},{"key":"10.1016\/j.jacep.2026.05.002_bib88","doi-asserted-by":"crossref","first-page":"396","DOI":"10.3389\/fphys.2013.00396","article-title":"\u03b2-Adrenergic receptor responsiveness in aging heart and clinical implications","volume":"4","author":"Ferrara","year":"2014","journal-title":"Front Physiol"},{"key":"10.1016\/j.jacep.2026.05.002_bib89","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1136\/pgmj.66.782.1050","article-title":"Cognitive impairment associated with beta-blockade in the elderly","volume":"66","author":"Rogers","year":"1990","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.jacep.2026.05.002_bib90","first-page":"909","article-title":"A review of the safety and efficacy of nebivolol in the mildly hypertensive patient","volume":"3","author":"Cockcroft","year":"2007","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.jacep.2026.05.002_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104274","article-title":"Antiarrhythmic mechanisms of beta blocker therapy","volume":"146","author":"Grandi","year":"2019","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jacep.2026.05.002_bib92","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1016\/j.hrthm.2016.09.012","article-title":"Beta-blocker therapy for long QT syndrome and catecholaminergic polymorphic ventricular tachycardia: are all beta-blockers equivalent?","volume":"14","author":"Ackerman","year":"2017","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2026.05.002_bib93","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s10557-008-6081-3","article-title":"Electrophysiological effects of carvedilol administration in patients with dilated cardiomyopathy","volume":"22","author":"Kanoupakis","year":"2008","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.jacep.2026.05.002_bib94","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jama.295.2.165","article-title":"Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC study: a randomized trial","volume":"295","author":"Connolly","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jacep.2026.05.002_bib95","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1093\/eurjhf\/hfs100","article-title":"Effect of nebivolol on outcome in elderly patients with heart failure and atrial fibrillation: insights from SENIORS","volume":"14","author":"Mulder","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacep.2026.05.002_bib96","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1124\/molpharm.121.000359","article-title":"\u03b2-Arrestin-biased allosteric modulator potentiates carvedilol-stimulated \u03b2 adrenergic receptor cardioprotection","volume":"100","author":"Wang","year":"2021","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jacep.2026.05.002_bib97","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.120.009591","article-title":"Bucindolol decreases atrial fibrillation burden in patients with heart failure and the ADRB1 Arg389Arg genotype","volume":"14","author":"Piccini","year":"2021","journal-title":"Circ Arrhythm Electrophysiol"}],"container-title":["JACC: Clinical Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X26004469?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X26004469?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T15:33:40Z","timestamp":1785339220000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405500X26004469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":97,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S2405500X26004469"],"URL":"https:\/\/doi.org\/10.1016\/j.jacep.2026.05.002","relation":{},"ISSN":["2405-500X"],"issn-type":[{"value":"2405-500X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selective Use of Nonselective Beta-Blockers","name":"articletitle","label":"Article Title"},{"value":"JACC: Clinical Electrophysiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacep.2026.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}